The Benefits and opportunities of entering the UK Market with MedTech Post Brexit & Successful Case Studies
Listen now
Description
This webinar featured an impressive group of panellists, including: -Michael Branagan-Harris, CEO, Device Access -James Lindley, Commercial Counselor, US Embassy London -Jeff Dillon, UK Dept International Trade DIT -Amit Kukreja, Vice President | Corporate Market Access & Reimbursement at Masimo Former Vice President, Global Marketing, Reimbursement and Patient Access at Second Sight Medica. Products -Dawn Smiles, Founder and Clinical Director at MedTec Consulting Ltd -Michael Kujak, Former Chief Marketing Officer & SVP International Commercialization NxThera Inc -John West, Director, Pellere Health
More Episodes
Published 08/03/22
As NHS waiting lists grow, the need for operational gains intensifies. Hospitals need to be able to make faster diagnoses and deliver more efficient treatments to free up bed space and admit more patients. The issue is not simply about the NHS working harder, but working smarter, and this is...
Published 08/03/22
The NHS's target is to become the world’s first 'net zero’ national health service. Their ambitious plan shows that the greatest areas of opportunity are in the supply chain, estates and facilities, pharmaceuticals and medical devices, and travel. What does this mean for the MedTech industry and...
Published 01/25/22